Panagora Asset Management’s Checkpoint Therapeutics CKPT Stock Holding History

Panagora Asset Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-531	Closed	-$16K	–	1840
2021 Q2	$16K	Hold	531	–	–	﹤0.01%	2187
2021 Q1	$17K	Hold	531	–	–	﹤0.01%	2329
2020 Q4	$14K	Sell	531 -309	-37%	-$7.82K	﹤0.01%	2247
2020 Q3	$22K	Hold	840	–	–	﹤0.01%	2180
2020 Q2	$17K	Hold	840	–	–	﹤0.01%	2166
2020 Q1	$13K	Buy	+840	New	+$14.9K	﹤0.01%	2106
2019 Q1	–	Sell	-903	Closed	-$16K	–	2513
2018 Q4	$16K	Sell	903 -1,119	-55%	-$26.6K	﹤0.01%	2255
2018 Q3	$72K	Sell	2,022 -97	-5%	-$3.39K	﹤0.01%	1939
2018 Q2	$63K	Buy	2,119 +901	+74%	+$31.1K	﹤0.01%	1986
2018 Q1	$53K	Buy	+1,218	New	+$52.9K	﹤0.01%	2012

Other funds holding CKPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return

Panagora Asset Management's CKPT Position: Q3 2021 in Review

Panagora Asset Management sold out of Checkpoint Therapeutics (CKPT) in Q3 2021, closing a stake of 531 shares — an estimated $16K sold.

Panagora Asset Management first reported a position in CKPT in Q1 2018 and held it in 10 quarters. The position peaked at $72K in Q3 2018. 67 funds tracked by Wall St. Rank hold CKPT as of Q3 2021.

Panagora Asset Management reported no remaining Checkpoint Therapeutics position as of Q3 2021 after selling out during the quarter.
Panagora Asset Management sold 531 Checkpoint Therapeutics shares in Q3 2021, an estimated $16K.
Panagora Asset Management first reported a position in Checkpoint Therapeutics in Q1 2018 and held it in 10 quarters.
Panagora Asset Management's Checkpoint Therapeutics position peaked at $72K in Q3 2018.
67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.